TopStocks.com - Premium Stock Alerts

    Nutriband Receives USPTO Notice of Publication of Commercial Brand Name Trademarks for Its Abuse Deterrent Fentanyl Patch

    September 8, 2026 · TopStocks

    Share

    Nutriband Receives USPTO Notice of Publication of Commercial Brand Name Trademarks for Its Abuse Deterrent Fentanyl Patch

    Nutriband has received a Notice of Publication from the United States Patent and Trademark Office (USPTO) for commercial brand name trademarks for its lead product, an abuse-deterrent fentanyl transdermal system.

    Once allowed, Nutriband plans to submit its commercial worldwide brand name to the FDA and other international regulatory agencies for approval.

    ORLANDO, Fla., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that it has received a Notice of Publication from the United States Patent and Trademark Office (USPTO) dated September 2, 2026 for commercial brand name trademarks for its lead product, an abuse-deterrent fentanyl transdermal system.

    The trademarks will be published in the USPTO Trademark Official Gazette. If no objections are filed during the 30-day opposition period, the USPTO is expected to issue a Notice of Allowance.

    Nutriband intends to secure full intellectual property rights for its commercial brand names in the United States and internationally. The proposed brand name and product labeling will be submitted to the FDA and other international regulatory agencies for review and approval.

    Nutriband's fentanyl transdermal system is based on its AVERSA™ abuse-deterrent transdermal technology and has the potential to be the world's first abuse-deterrent patch designed to deter abuse and misuse while reducing the risk of accidental exposure to transdermal fentanyl.

    Nutriband's abuse-deterrent fentanyl transdermal system has the potential to reach peak annual U.S. sales of $80 million to $200 million.¹ While initially concentrating on the U.S. market, the unmet medical need for adequate pain management is a global problem, and the product is being developed for major medical markets worldwide.

    Nutriband's AVERSA™ abuse-deterrent technology is utilized to incorporate aversive agents into transdermal patches to help prevent the abuse, diversion, misuse and accidental exposure of drugs with abuse potential, including opioids and stimulants.

    The AVERSA™ technology is protected by a broad international intellectual property portfolio, with patents issued in 46 countries, including the United States, Europe, Japan, Korea, Russia, China, Canada, Mexico and Australia.


    ¹ Health Advances AVERSA Fentanyl market analysis report, 2022.

    About AVERSA™ Abuse-Deterrent Transdermal Technology

    Nutriband's AVERSA™ abuse-deterrent transdermal technology incorporates aversive agents into transdermal patches to prevent the abuse, diversion, misuse and accidental exposure of drugs with abuse potential.

    The technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, such as fentanyl, while helping ensure that these medications remain accessible to patients who need them.

    AVERSA™ is covered by a broad intellectual property portfolio, with patents granted in the United States, Europe, Japan, Korea, Russia, China, Canada, Mexico and Australia.

    About Nutriband, Inc.

    Nutriband Inc. is primarily engaged in the development of a portfolio of transdermal pharmaceutical products.

    The Company's lead product under development is an abuse-deterrent fentanyl patch incorporating its AVERSA™ abuse-deterrent technology. AVERSA™ technology can be incorporated into transdermal patches to help prevent the abuse, misuse, diversion and accidental exposure of drugs with abuse potential.

    The Company's website is www.nutriband.com. Any material contained in or derived from the Company's website or any other website is not part of this press release.

    Forward-Looking Statements

    Certain statements contained in this press release, including, without limitation, statements containing the words "believes," "anticipates," "expects" and words of similar import, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

    Such forward-looking statements involve both known and unknown risks and uncertainties. The Company's actual results may differ materially from those anticipated in its forward-looking statements as a result of a number of factors, including the Company's ability to develop its proposed abuse-deterrent fentanyl transdermal system and other proposed products; its ability to obtain patent protection for its abuse-deterrent technology; its ability to obtain the necessary financing to develop products and conduct necessary clinical testing; and its ability to obtain U.S. Food and Drug Administration approval to market any product it may develop in the United States.

    Additional risks include the Company's ability to obtain other regulatory approvals necessary to market products internationally, including in Europe; its ability to successfully market products it may develop; its ability to create, sustain, manage or forecast growth; its ability to attract and retain key personnel; changes in business strategy or development plans; competition; business disruptions; adverse publicity; and international, national and local general economic and market conditions.

    These risks also include those generally associated with an undercapitalized developing company, as well as the risks contained under "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the Company's Form S-1, Forms 10-K and Forms 10-Q, and other filings with the Securities and Exchange Commission.

    Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statements to reflect any event or circumstance that may arise after the date hereof.

    Nutriband is a registered trademark of Nutriband, Inc. AVERSA is a trademark of Nutriband, Inc.

    Brand Institute and Drug Safety Institute are registered trademarks of Brand Institute, Inc.

    Contact Information

    Nutriband Inc.

    Phone: 407-377-6695
    Email: info@nutriband.com

    SOURCE: Nutriband Inc.

    Enjoyed this breakdown?

    Don't miss our next early stock alert.
    Join our SMS list and get real time picks sent straight to your phone the moment we release them.

    Fast, free, zero spam. Opt out anytime.

    By joining, you agree to receive recurring SMS alerts from TopStocks. Message and data rates may apply. Reply STOP to unsubscribe.

    MASTER LEGAL DISCLAIMER

    Last Updated: Sep 07, 2026

    Publisher: Relqo Media LLC (Wyoming, United States)

    Subject Company: Nutriband Inc. (NTRB)

    IMPORTANT SUMMARY, PLEASE READ FIRST

    This website and any affiliated digital materials are published by Relqo Media LLC, a Wyoming marketing agency that has been compensated in cash to produce and distribute promotional content regarding Nutriband Inc. (NASDAQ: NTRB). This communication is a paid advertisement, not a research report, not investment advice, and not an independent publication. Relqo Media is not a broker dealer, investment adviser, or securities analyst. Investing in small cap or microcap securities is extremely speculative and may result in the total loss of your investment. We strongly urge all viewers to consult a licensed investment professional and perform their own due diligence.

    1. NATURE AND INTENT OF THIS COMMUNICATION

    Relqo Media LLC is a for profit marketing agency engaged in paid promotions of public companies. The content we produce is strictly commercial and intended to create temporary public awareness, visibility, and short term market activity around the featured company. This material is not impartial. All readers should interpret our content as a paid commercial advertisement and not as an editorial, research article, or independent commentary. We create advertisements, not analysis. These communications are not intended to be factual evaluations of the company's operations or investment merit.

    2. COMPENSATION FOR Nutriband Inc. (NTRB)

    Relqo Media LLC has been engaged by Penzance LLC to provide investor awareness and promotional media services for Nutriband Inc. (NASDAQ: NTRB).

    • Relqo Media LLC has received $37,500 in cash compensation from Penzance LLC for a three-day investor awareness campaign commencing on September 8, 2026 and concluding on September 10, 2026.
    • Total aggregate cash compensation received by Relqo Media LLC in connection with Nutriband Inc. is $37,500.
    • Penzance LLC and/or its affiliates may currently own, or may in the future acquire or dispose of, securities of NTRB. Any such ownership interests, whether past, present, or future, represent a potential material conflict of interest.
    • This financial arrangement creates a direct, material, and unavoidable conflict of interest. All materials, opinions, and content distributed by Relqo Media LLC concerning NTRB must be considered promotional, financially motivated, and intended for the benefit of Penzance LLC.
    • Relqo Media LLC is not, and does not represent itself to be, a licensed broker dealer, registered investment adviser, or financial analyst. The content provided is not investment advice, an offer to buy or sell securities, or a recommendation to engage in any investment activity.
    • Recipients of this content should perform their own due diligence, consult licensed financial professionals, and assume that any statements regarding NTRB are materially influenced by the compensation and potential ownership interests involved.
    • Neither Relqo Media LLC nor Penzance LLC make any representation, warranty, or guarantee as to the accuracy, timeliness, or completeness of the information provided, and NTRB expressly disclaim any liability for investment losses that may result from reliance on such promotional materials.

    3. INTENDED AUDIENCE

    These communications are directed solely to U.S.-based, self-directed investors who understand the risks of investing in microcap and NASDAQ listed securities. The content is not intended for children, seniors, retirement accounts, or individuals with limited experience in securities trading. These communications are not intended to guide investment for long-term portfolio management or financial planning purposes.

    4. NO ENDORSEMENT OR VERIFICATION OF COMPANY CLAIMS

    Relqo Media LLC does not, and has not, independently verified, investigated, audited, or substantiated any statements, representations, or claims made by the featured company, its officers, directors, employees, affiliates, agents, press releases, marketing materials, or any third-party sources.

    Any and all information regarding Nutriband Inc. (NASDAQ: NTRB), including but not limited to business descriptions, operating updates, acquisitions, revenue projections, financing arrangements, partnerships, inventory growth, expansion plans, or strategic plans, should be assumed to be unverified, unaudited, incomplete, potentially inaccurate, and subject to change without notice.

    We make no warranties or representations as to the truthfulness, accuracy, reliability, or completeness of such information, and you should not interpret our publication of these statements as an endorsement or confirmation of their validity.

    You should not rely on any company provided claims, projections, or forward looking statements for the purpose of making an investment decision. All such statements may be speculative, overstated, selectively presented, or based on assumptions that may never materialize.

    If you choose to invest, you do so entirely at your own risk, and you should conduct thorough, independent due diligence, including reviewing SEC filings, consulting licensed investment professionals, and obtaining independent verification of any material facts, before making any investment decision.

    5. MARKET INFLUENCE AND TRADING PATTERN EXPECTATION

    Historically, promotional campaigns for microcap and small-cap securities, particularly those driven by paid advertising, often cause temporary, artificial, and unsustainable increases in share price and trading volume. These movements are typically fueled by short-term speculative interest, promotional circulation, algorithmic trading activity, and momentum-based retail buying rather than any change in the underlying business, operations, or financial condition of the company.

    You should assume and expect that:

    • NTRB's share price may experience sharp, rapid, and potentially extreme increases during the period of active promotion;
    • Trading volume may spike dramatically due to speculative buying pressure, news catalysts amplified by promotional activity, and social media or online forum chatter;
    • Once buying interest subsides, selling begins, or the promotion ends, which may occur suddenly and without notice, the share price may decline precipitously, potentially returning to pre-promotion levels or lower, often within days or even hours; and
    • These price and volume movements are not reflective of intrinsic value and may have no correlation to the company's actual fundamentals or long-term business prospects.

    Past market behavior shows that such promotional price spikes are frequently followed by steep losses, which can be rapid and irreversible. If you purchase shares during or shortly after a promotional period, you should be prepared for the high probability of losing a substantial portion, or all, of your investment.

    By engaging with our content, you acknowledge and agree that you fully understand the speculative, volatile, and high-risk nature of securities subject to promotional activity, and you will not hold Relqo Media LLC responsible for any losses resulting from such trading patterns.

    6. NO RELIANCE, INVESTOR RESPONSIBILITY

    The burden of research, verification, and risk assessment rests entirely with you, the reader. All content produced and distributed by Relqo Media LLC is promotional in nature and should not be the basis for any investment decision. We are not responsible for your interpretation or use of the information contained herein.

    You are solely responsible for:

    • Reviewing and analyzing all publicly available information, including but not limited to SEC filings, audited financial statements, and official company disclosures;
    • Consulting with a licensed, qualified investment professional, attorney, or tax adviser before making any investment decision;
    • Understanding and accepting the risks inherent in microcap and early-stage public companies, which may include extreme volatility, illiquidity, lack of financial transparency, insider selling, share dilution, regulatory challenges, and business failure.

    We make no warranties or representations as to the accuracy, completeness, timeliness, or reliability of any information presented. Any data, figures, or statements regarding the featured company's business, market opportunity, future performance, or partnerships may be incomplete, outdated, or incorrect. You should assume that certain information is based on third-party sources we have not independently verified.

    By viewing our materials, you agree that:

    • You will not rely solely on our communications in making an investment decision;
    • You accept full responsibility for conducting independent due diligence; and
    • Relqo Media LLC and its affiliates will not be liable for any losses or damages arising from your reliance on our content.

    7. FORWARD-LOOKING STATEMENTS, ASSUMPTIONS, AND ACCURACY NOTICE

    Our materials may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as well as predictive or aspirational language regarding future events, performance, or results. Words such as "anticipates," "expects," "intends," "plans," "believes," "may," "will," "should," "could," "projects," "estimates," "potential," and similar expressions are intended to identify such statements. These statements are inherently uncertain, based on current expectations, estimates, and assumptions that may prove to be incorrect, incomplete, or no longer applicable at the time you read them.

    Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied. Such factors include, but are not limited to, changes in market conditions, financing availability, integration risks, consumer demand, competitive pressures, and broader economic or geopolitical developments.

    Additionally, some information presented in our content is derived from third-party sources, company press releases, or statements from officers, directors, or affiliates of the featured company. We do not independently verify or guarantee the accuracy, completeness, or timeliness of such information. Any claim, projection, or forward-looking statement should be considered purely speculative and potentially outdated.

    You should not place undue reliance on forward-looking statements or assume that they will prove to be accurate. Relqo Media LLC undertakes no obligation to update or revise any forward-looking statements to reflect subsequent events, changes in circumstances, or the emergence of new information, except as required by law.

    8. INFORMATION SOURCING, BIAS, AND ACCURACY

    We use publicly available information including company websites, press releases, and promotional materials supplied by paying clients or related parties. We do not verify or validate this data.

    Assume all information presented by Relqo Media is:

    • Subjective,
    • Not independently verified,
    • Created to highlight potential upside and omit downsides,
    • Not suitable as the basis for any investment decision.

    9. OWNERSHIP AND TRADING CONFLICTS

    Relqo Media LLC, its contractors, members, and affiliates may hold or acquire shares in the companies we promote, including NTRB. We may buy or sell such shares without prior notice. These transactions may occur before, during, or after a promotional campaign and may affect market pricing. We are not obligated to update readers on our trading activity or affiliate holdings.

    10. MARKETING TOOLS, DATA COLLECTION, AND USER CONSENT

    We use a range of outreach and promotional tools, including:

    • Email and newsletter distributions,
    • SMS/MMS text campaigns,
    • Social media posts and influencers,
    • Google and native display ads,
    • Press releases, video marketing, and paid content distribution.

    By engaging with our content, you consent to receive ongoing marketing communications. You may unsubscribe, but your data may be retained for audit or compliance purposes. Please refer to our Privacy Policy for further details.

    11. ADVERTISING LAW COMPLIANCE

    Relqo Media LLC produces promotional content in accordance with the advertising disclosure standards set forth by the Federal Trade Commission (FTC) and the SEC's interpretations of sponsored investment-related communications.

    We make good-faith efforts to disclose all:

    • Compensation arrangements,
    • Conflicts of interest,
    • Risks,
    • Limitations of our role, and
    • The promotional nature of this content.

    We do not provide investment recommendations under any regulatory framework including, but not limited to, SEC Regulation Analyst Certification, FINRA Rule 2210, or Regulation Best Interest.

    12. NON-U.S. USERS

    This material is intended solely for distribution within the United States. If you are accessing this site from outside the U.S., you are responsible for complying with your country's laws. Relqo Media disclaims liability for access from non-U.S. jurisdictions where investor promotion, marketing, or solicitation of securities is restricted or prohibited.

    13. DISCLAIMER OF WARRANTIES AND LIMITATION OF LIABILITY

    All content is provided as is and without warranties of any kind, either express or implied. Relqo Media LLC disclaims any and all liability for:

    • Investment losses,
    • Inaccuracies,
    • Technical delays,
    • User misunderstandings,
    • Omissions or errors in content.

    Total liability for any claim shall not exceed one hundred dollars ($100).

    14. LEGAL GOVERNANCE AND DISPUTE RESOLUTION

    All matters arising out of this disclaimer shall be governed by the laws of the State of Wyoming. You agree that any dispute shall be resolved exclusively through binding arbitration under the rules of the American Arbitration Association, to be held in Sheridan County, Wyoming. Class action claims and group arbitration are expressly prohibited.

    15. NON-SOLICITATION AND GEOGRAPHIC LIMITATIONS

    Nothing in our content constitutes a general solicitation or a personal securities recommendation. If you reside in a jurisdiction where such communications are unlawful, you must exit this site and discontinue engagement with our content.

    16. FINAL NOTICE, ACCEPTANCE OF TERMS

    We reserve the right to update this disclaimer at any time without notice. Your continued use of our services or content constitutes acceptance of the most recent version.

    If you do not accept all terms of this disclaimer in full, you must:

    • Exit our websites,
    • Unsubscribe from our communications,
    • Discontinue viewing all Relqo Media promotional content.

    17. NO RELIANCE

    By viewing or engaging with this content, you agree that:

    • You will not rely on any statements made by Relqo Media for investment purposes,
    • You waive any claim that our content was a material factor in your investment decision,
    • You have read, understood, and accepted this disclaimer in full.

    © 2024 Relqo Media LLC. All Rights Reserved.

    Legal Contact: support@topstocks.com

    Mailing Address: 1309 Coffeen Ave Ste 1200, Sheridan, WY 82801

    Affiliate Disclosure: Relqo Media LLC owns and operates TopStocks.com and all affiliated digital properties.